Taipei, Taiwan

Chia-Shun Shih

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gongwin Biopharm Co., Ltd. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chia-Shun Shih. Retrieved from https://idiyas.com/inventor/chia-shun-shih

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chia-Shun Shih: Innovator in Anti-Tumor Pharmaceutical Composition

Introduction

Chia-Shun Shih is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that exhibit anti-tumor activity. His work is crucial in the ongoing fight against cancer, providing new methods for treatment and tumor growth inhibition.

Latest Patents

Chia-Shun Shih holds a patent for a pharmaceutical composition that demonstrates anti-tumor activity. This composition includes para-toluenesulfonamide (PTS) and a pharmaceutically acceptable carrier. The invention is specifically designed for treating squamous-cell carcinoma. Additionally, it outlines methods for treating patients suffering from cancer and inhibiting tumor growth.

Career Highlights

Chia-Shun Shih is associated with Gongwin Biopharm Co., Ltd., where he continues to advance his research and development efforts. His innovative approach to pharmaceutical compositions has positioned him as a key figure in the industry.

Collaborations

Chia-Shun Shih collaborates with talented individuals such as Mao-Yuan Lin and Nanshan Zhong, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the pharmaceutical field.

Conclusion

Chia-Shun Shih's contributions to anti-tumor pharmaceutical compositions represent a significant advancement in cancer treatment. His innovative work continues to inspire and pave the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…